Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 8.55
-0.17 (-1.95%)
Feb 11, 2026, 2:58 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 3.58 billion as of February 13, 2026. Its market cap has decreased by -39.77% in one year.
Market Cap
3.58B
Enterprise Value
3.43B
Revenue
246.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.55
Market Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 3.58B, a decrease of -29.90%. That is a compound annual growth rate of -10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.58B | 3.01% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 6.49B |
| SCI Pharmtech | 6.21B |
| Easywell Biomedicals | 4.08B |
| Orient EuroPharma | 3.83B |
| Maywufa Company | 2.92B |
| PhytoHealth | 2.89B |
| Golden Biotechnology | 2.71B |
| Johnson Chemical Pharmaceutical Works | 2.55B |